Jochen H. Lorch

10.6k citations
123 papers · 5.5k · 4 hit papers · h-index 32

Impact in

    • Head and Neck Cancer Studies
  • Oncology top 0.5%
    • Cancer Immunotherapy and Biomarkers
    • Polyomavirus and related diseases

Papers in

    • Cancer Immunotherapy and Biomarkers 11
    • Polyomavirus and related diseases 7
    • Ear and Head Tumors 5
    • Head and Neck Cancer Studies 39

Jochen H. Lorch

115 papers receiving 5.4k citations

Jochen H. Lorch's Hit Papers

Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial 2016 · 940 citations
9400+5+10Years since publication250500750

Peers

Jochen H. Lorch
Comparison fields: 5 of 109
  • Otorhinolaryngology 1.7k
  • Oncology 2.4k
  • Endocrinology, Diabetes and Metabolism 451
  • Cancer Research 404
  • Immunology 532
Replace Glenn J. Hanna with:
Glenn J. Hanna United States
Renata Ferrarotto United States
Cécile Badoual France
Jaana Hagström Finland
B Luboïnski France
Uta Drebber Germany
K. Kian Ang United States
Jonathan D. Schoenfeld United States
W.H. Lau China
Ravindra Uppaluri United States
Jochen H. Lorch relative to Glenn J. Hanna United States Glenn J. Hanna's profile →
Citations per field
00.5×5.8×
Glenn J. Hanna · 1×
Citations per year

Countries citing papers authored by Jochen H. Lorch

Since Specialization
Citations

This map shows the geographic impact of Jochen H. Lorch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jochen H. Lorch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jochen H. Lorch more than expected).

Fields of papers citing papers by Jochen H. Lorch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jochen H. Lorch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jochen H. Lorch. The network helps show where Jochen H. Lorch may publish in the future.

Co-authors

The 25 scholars most cited alongside Jochen H. Lorch, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jochen H. Lorch Line = papers co-authored together Jochen H. Lorch links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 123 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial
Hit paper breakdown →
2016940
2
Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): a randomised phase 3 trial
Hit paper breakdown →
2013492
3
Survival and human papillomavirus in oropharynx cancer in TAX 324: a subset analysis from an international phase III trial
Hit paper breakdown →
2011355
4
Induction chemotherapy with cisplatin and fluorouracil alone or in combination with docetaxel in locally advanced squamous-cell cancer of the head and neck: long-term results of the TAX 324 randomised phase 3 trial
Hit paper breakdown →
2011315
5 2018238
6 2014236
7 2009224
8 2015212
9 2018201
10 2013134
11 2004125
12 2020109
13 201095
14 201473
15 201671
16 201768
17 201158
18 201955
19 202053
20 200752

About Jochen H. Lorch

Jochen H. Lorch is a scholar working on Oncology, Otorhinolaryngology, Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology, having authored 123 papers that have together received 5.5k indexed citations. Recurring topics across this work include Head and Neck Cancer Studies (39 papers), Thyroid Cancer Diagnosis and Treatment (28 papers), Cancer Immunotherapy and Biomarkers (11 papers), Salivary Gland Tumors Diagnosis and Treatment (10 papers), Polyomavirus and related diseases (7 papers), Lung Cancer Treatments and Mutations (7 papers), BRCA gene mutations in cancer (6 papers) and Ear and Head Tumors (5 papers). The work is most often cited by research in Otorhinolaryngology (1.7k citations), Oncology (2.4k citations), Endocrinology, Diabetes and Metabolism (451 citations), Cancer Research (404 citations) and Immunology (532 citations). Jochen H. Lorch has collaborated with scholars based in United States, France and Germany. Frequent co-authors include Robert I. Haddad, Marshall R. Posner, Nicholas J. Sarlis, Roy B. Tishler, Glenn J. Hanna, Olga Goloubeva, Kevin J. Cullen, Michèle Milella, Omid Hamid and Howard L. Kaufman. Their work appears in journals such as Journal of Clinical Oncology, Oral Oncology, International Journal of Radiation Oncology*Biology*Physics, Head & Neck and The Oncologist.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact